Background: Limited data exist on regression or progression of coronary artery aneurysms (CAA) in higher risk patients with Kawasaki disease (KD) in the current era of early treatment with immunomodulatory and anticoagulation therapy. Coronary risk classification in KD is defined by: Class I with no coronary artery involvement, Class II with transient coronary ectasia that disappears within 6-8 weeks, Class III with 1 small-medium CAA, Class IV with >=1 large or giant CAA, and Class V with coronary artery occlusion. We assessed the hypothesis that Class III-V CAA may regress, but coronary artery dimensions often do not normalize.
